Labaid

What Labaid does

Labaid Group is a privately held Bangladeshi healthcare conglomerate founded in 1989 by Dr. A M Shamim, headquartered in Dhaka, operating one of the country's largest private healthcare platforms. The group runs four specialty hospitals — Labaid Cardiac Hospital (2003), Labaid Specialized Hospital (2006), Labaid Specialized Hospital Chattogram, and Labaid Cancer Hospital and Super Specialty Centre (2021, the only JCI-accredited hospital in Bangladesh) — alongside 35+ diagnostic centers spanning Dhaka and 20+ districts. Service lines span cardiology, oncology (linear accelerator therapy, PET-CT imaging, robotic surgery, bone marrow transplantation), tertiary multi-specialty care, preventive health check-ups, vaccination, telemedicine, and an in-house pharmaceuticals subsidiary (Labaid Pharmaceuticals Ltd.) with 7,000+ employees; the group also controls education (State University of Bangladesh, State College of Health Sciences), real estate, and agro subsidiaries.

The platform is built around advanced clinical technology and an internationally accredited quality stack (JCI for oncology, NABH for cardiac and specialized hospitals, CAP for diagnostics), supported by ~1,000 consultant physicians and 18,000+ total professionals, serving nearly 3 million patient encounters annually. Revenue is generated through fee-for-service hospital care, diagnostic testing, preventive health packages priced from 2,600 to 18,900 Taka, vaccinations, corporate wellness programs, and pharmaceutical manufacturing/sales, distributed via walk-in hospital and diagnostic footfall, a 10606 hotline, online appointment booking, telemedicine, and direct corporate sales.

The go-to-market is primarily direct-to-consumer across Bangladesh, with a B2B corporate wellness overlay and an integrated pharmacy supply chain. Distribution is anchored by the nationwide diagnostic network that funnels volume into higher-acuity hospital services, reinforced by education institutions that feed the clinical talent pipeline. Expansion plans include 2,500+ additional beds, 30 satellite cancer centers over five years, a 750-bed quaternary super-specialty hospital, and new hospital builds in Uttara, Narayanganj, and Chattogram — collectively signaling a step-change in capacity and clinical depth.

Name

Labaid

Legal name

Labaid

Website

https://labaidgroup.com

Company type

Private

Founded year

1989

Operating status

Operating

Headcount range

101–250 employees

Short description

Labaid Group is a privately held Bangladeshi healthcare conglomerate operating four specialty hospitals, 35+ diagnostic centers, a pharmaceuticals subsidiary, and education institutions, serving nearly 3 million patients annually across the country.

Ownership category

akta.pro rank

Product category

Private Hospital and Diagnostic Services

NAICS

Medical Laboratories (621511), Specialty (except Psychiatric and Substance Abuse) Hospitals (62231)

SIC

Services-Medical Laboratories (8071), Services-Hospitals (8060)

akta.pro primary industry

Cardiac & Cardiothoracic Specialty Hospitals (HLAFAHAA)

akta.pro secondary industry

Central Laboratory Services (Core Lab Operations) (HLAGAEAA)

Keywords

• Private healthcare services
• Diagnostic center network
• Tertiary hospital care
• Oncology and cardiac care
• Preventive health packages

Headquarters

HQ city

Dhaka

HQ country

Bangladesh

HQ region

Asia

Offices18 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Hospital Services: Inpatient and outpatient medical services across multiple specialty hospitals including cardiac, cancer, and general/specialized care with ICU, NICU, and surgical services
2. Diagnostic Services: Pathology and imaging services through 35+ diagnostic centers across Bangladesh offering pathology, radiology, and specialized testing
3. Health Check-up Packages: Preventive health screening packages ranging from basic to comprehensive cardiac, cancer, and general health assessments for individuals and corporates
4. Vaccination Services: Immunization services with various vaccines for children and adults
5. Pharmaceuticals: Labaid Pharmaceuticals Ltd. manufactures and distributes pharmaceutical products with over 7,000 employees

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels5 records

Core offering

Labaid Group operates an integrated private healthcare delivery platform in Bangladesh comprising four super-specialty hospitals (cardiac, cancer, specialized, and Chattogram), a network of 35+ diagnostic centers providing pathology and imaging services, preventive health check-up packages, telemedicine consultations, and pharmaceutical manufacturing through Labaid Pharmaceuticals Ltd. Services span tertiary and quaternary care including cardiac surgery, oncology, orthopedics, neurology, nephrology, IVF, and emergency medicine, supported by advanced medical technology such as linear accelerators, PET-CT, and robotic surgery systems.

Product overview

Labaid is one of Bangladesh's largest private healthcare brands operating a diversified healthcare ecosystem. The portfolio consists of four NABH-accredited hospitals (LABAID Cancer Hospital with JCI accreditation, LABAID Cardiac Hospital, LABAID Specialized Hospital, and LABAID Specialized Hospital Chattogram), a nationwide network of over 35 Labaid Diagnostic centres with CAP accreditation, Labaid Pharmaceuticals, telemedicine services, health check-up packages, and educational institutions. The hospitals provide tertiary and super-specialty care across oncology, cardiac, surgical, orthopaedic, neurological, urological, nephrological, and other specialties. The diagnostic network provides pathology, radiology, and imaging services across Bangladesh. This platform-plus-extensive-network model delivers 360-degree healthcare services from diagnosis to treatment to education.

Differentiator

Problem solved

Functional benefit

Products and services

• LABAID Cancer Hospital and Super Specialty Centre Bangladesh's only JCI-accredited multi-disciplinary super-specialty tertiary care cancer hospital offering comprehensive oncology services including linear accelerator therapy, PET-CT imaging, robotic surgery, and bone marrow transplantation for cancer patients.
• LABAID Cardiac Hospital Specialized cardiac hospital offering comprehensive heart care including angiography, angioplasty, bypass surgery, and other cardiovascular treatments with NABH accreditation for cardiac patients.
• LABAID Specialized Hospital Leading tertiary care hospital offering surgery, orthopedics, neurosurgery, urology, nephrology, medicine, ICU, NICU, and IVF services with NABH accreditation.
• LABAID Specialized Hospital Chattogram

Quantifiable outcome

• Treated over 300,000 patients since 2021
• +2 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• Labaid Cancer Hospital and Super Specialty CentrecoreOthers · 1 January 2021Labaid Cancer Hospital and Super Specialty Centre is Bangladesh's only Joint Commission International (JCI)-accredited hospital, established to address the country's rising cancer burden. The facility offers comprehensive oncology services and has treated over 300,000 patients since its establishment in 2021.

Scale indicators9 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Metropolis Healthcare Limited: India's leading diagnostic chain with CAP/NABL-accredited pathology labs and a pan-India network. Most relevant comparable to Labaid's 35+ diagnostic center network for unit economics and geographic expansion analysis.
• United Hospital Limited: Dhaka-based tertiary care hospital competing directly with Labaid's Cardiac and Specialized hospitals for high-acuity private patients. Overlapping specialty mix including cardiac surgery, oncology, and diagnostics makes it the closest like-for-like competitor in Bangladesh.
• Square Hospitals Limited: Bangladesh-based multi-specialty private hospital in Dhaka operating tertiary care across cardiac, oncology, and general specialties. Direct competitor sharing the same private-pay urban patient pool that Labaid targets with its specialty hospital portfolio.
• Evercare Hospital Dhaka: JCI-accredited multi-specialty hospital in Dhaka operated by Evercare Group, directly contesting Labaid's premium tier cardiac and cancer patients with comparable technology and international accreditation positioning.
• Popular Diagnostic Centre: Bangladesh's largest diagnostic network competing head-to-head with Labaid's 35+ diagnostic centers across pathology, imaging, and health screening services for the same walk-in patient base.

Regional players

• Bangkok Dusit Medical Services (BDMS): Thailand's largest private hospital network and a regional medical tourism hub with JCI-accredited facilities. Comparable in international accreditation strategy and serves as the high-end benchmark for Labaid's quaternary hospital aspiration.

Broad incumbents

• Apollo Hospitals Enterprise: India's largest hospital chain with JCI-accredited tertiary and quaternary care facilities across multiple specialties. Comparable diversified hospital-plus-pharmacy-plus-clinic model at greater scale and a known source of medical tourism outflows from Bangladesh.
• Fortis Healthcare Limited: Indian multi-specialty hospital network with NABH/JCI-accredited facilities and integrated diagnostics. Direct counterpart in clinical service mix (cardiac, oncology, tertiary care) for benchmarking Labaid's specialty expansion strategy.
• Manipal Hospitals: Indian multi-specialty hospital chain focused on quaternary and tertiary care including oncology and cardiac specialties, recently expanding across borders. Similar super-specialty + diagnostics + medical-tourism playbook to Labaid's strategic roadmap.
• IHH Healthcare Berhad: Malaysia-headquartered hospital operator with Mount Elizabeth, Gleneagles, and Acibadem brands across Asia. Provides a precedent for cross-border private hospital consolidation that Labaid could pursue given its only-JCI-in-Bangladesh position.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/labaidgroup
• LinkedInlinkedin.com/company/labaid-group

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries10 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Labaid